Condition 1: Peptic ulcer with bleeding. Condition 2: Acute gastritis with bleeding. Condition 3: Ulcer of esophagus with bleeding. Condition 4: Duodenitis with bleeding. Chronic or unspecified peptic ulcer, site unspecified, with hemorrhage Acute gastritis with bleeding Ulcer of esophagus with bleeding Duodenitis with bleeding
Conditions
Interventions
Intervention 1: Intervention group: The intervention group, which includes 83 people, will be kept fasting for 24 hours after the endoscopy, if they meet the conditions to enter the study, and during
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age 18-65 years old Patients with bleeding due to peptic ulcer, both stomach and duodenum, and bleeding due to erosive esophagus, stomach and duodenum Patients with active bleeding, visible vessel without active bleeding and adherent clot based on Forrest's classification and endoscopic diagnosis Patients with a BMI between 18.5-35
Exclusion criteria
Exclusion criteria: Patients admitted to the intensive care unit Patients with bleeding due to varicose veins, caustic substances Patients with gastrointestinal cancers Patients with clean base and flat pigmented spot ulcers Patients whose bleeding has not been treated Patients with gastrointestinal surgeries such as bariatric surgeries Patients who have been kept fasting for other reasons pregnant women Unwillingness to continue cooperation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of rebleeding within 7 days after endoscopic therapy. Timepoint: Day 7 after receiving endoscopic therapy. Method of measurement: Questionnaire with confirmation of diagnosis by endoscopy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of rebleeding within 14 days after treatment. Timepoint: Day 14. Method of measurement: Questionnaire with confirmation of endoscopic diagnosis.;Occurrence of rebleeding within 30 days after treatment. Timepoint: Day 30. Method of measurement: Questionnaire with confirmation of endoscopic diagnosis.;Body weight. Timepoint: The beginning of the study, the time of discharge from the hospital, the end of the study. Method of measurement: Digital scale with 100 gram accuracy.;Duration of hospitalization after treatment. Timepoint: When discharged from the hospital. Method of measurement: Using the patient's medical record.;Nutritional status of the patient. Timepoint: The beginning of the study, the time of discharge from the hospital, the end of the study. Method of measurement: "Nutritional risk screening-2002" questionnaire.;Body mass index. Timepoint: The beginning of the study, the time of discharge from the hospital, at the end of the study. Method of measurement: Quetelet equation.;Arm circumference. Timepoint: The beginning of the study, the time of discharge from the hospital, at the end of the study. Method of measurement: tape measure.;Serum albumin. Timepoint: The beginning of the study, the time of discharge from the hospital, at the end of the study. Method of measurement: Blood sample.;Serum total protein. Timepoint: The beginning of the study, the time of discharge from the hospital, at the end of the study. Method of measurement: Blood sample.;Gastrointestinal clinical symptoms. Timepoint: During hospitalization, at the end of the study. Method of measurement: "Gastrointestinal Symptom Rating Scale (GSRS)" questionnaire.;The level of patient satisfaction with the diet plan during hospitalization. Timepoint: During hospitalization. Method of measurement: questionnaire.;Pain score. Timepoint: At the beginning of the study, during hospitalization, at the end of the study. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzad Shidfar
Iran University of Medical Sciences
Outcome results
None listed